We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.5B
AUM Growth
+$6.37B
Cap. Flow
+$123M
Cap. Flow %
0.28%
Top 10 Hldgs %
9.32%
Holding
3,484
New
550
Increased
1,237
Reduced
1,116
Closed
366

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$301M
2
TSLA icon
Tesla
TSLA
+$254M
3
NKE icon
Nike
NKE
+$248M
4
PG icon
Procter & Gamble
PG
+$233M
5
PFE icon
Pfizer
PFE
+$232M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 10.23%
3 Consumer Discretionary 10.17%
4 Healthcare 10.17%
5 Industrials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFS
3151
DELISTED
Discover Financial Services
DFS
-18,594
Closed -$1.61M
DIST
3152
DELISTED
Distoken Acquisition Corp
DIST
-131,250
Closed -$1.38M
DMYY
3153
DELISTED
dMY Squared
DMYY
-150,000
Closed -$1.57M
DOCS icon
3154
Doximity
DOCS
$4.51B
-63,530
Closed -$1.35M
DOMH icon
3155
Dominari Holdings
DOMH
$62.5M
-11,679
Closed -$27.1K
DOO
3156
Bombardier Recreational Products
DOO
$4.99B
-96,850
Closed -$7.35M
DSI icon
3157
iShares MSCI KLD 400 Social ETF
DSI
$5.51B
-24,600
Closed -$2M
DTE icon
3158
CALL
DTE Energy
DTE
$28.1B
-6,000
Closed -$596K
DX
3159
Dynex Capital
DX
$3.23B
-33,401
Closed -$399K
DYN icon
3160
Dyne Therapeutics
DYN
$4.87B
-24,400
Closed -$219K
ED icon
3161
Consolidated Edison
ED
$39.3B
-18,490
Closed -$1.58M
EFXT
3162
Enerflex
EFXT
$2.48B
-67,378
Closed -$386K
EHAB
3163
DELISTED
Enhabit
EHAB
-43,063
Closed -$484K
EME icon
3164
Emcor
EME
$34.3B
-2,552
Closed -$537K
EPIX
3165
DELISTED
ESSA Pharma
EPIX
-15,188
Closed -$46.9K
EWG icon
3166
iShares MSCI Germany ETF
EWG
$1.72B
-11,900
Closed -$312K
EXC icon
3167
Exelon
EXC
$45.1B
-377,461
Closed -$14.3M
EXPO icon
3168
Exponent
EXPO
$3.34B
-2,784
Closed -$238K
FBK icon
3169
FB Financial Corp
FBK
$2.93B
-61,696
Closed -$1.75M
FCF icon
3170
First Commonwealth Financial
FCF
$2.13B
-19,960
Closed -$244K
FDL icon
3171
First Trust Morningstar Dividend Leaders Index Fund
FDL
$8.06B
-33,391
Closed -$1.12M
FDMT icon
3172
4D Molecular Therapeutics
FDMT
$875M
-101,863
Closed -$1.3M
FFBC icon
3173
First Financial Bancorp
FFBC
$3.47B
-33,811
Closed -$663K
FHB icon
3174
First Hawaiian
FHB
$3.2B
-554,599
Closed -$10M
FIBK icon
3175
First Interstate BancSystem
FIBK
$3.57B
-33,638
Closed -$839K

Similar funds

John Overdeck's Q4 2023 Portfolio in Review

As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
  • John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
  • John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
  • John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
  • John Overdeck opened 550 new positions and closed 366 in Q4 2023.
  • John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.